Atlas Trials

C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma

Clinical trial NCT06210243 · TERMINATED

Trial details

NCT number
NCT06210243
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma, B-CellCAR-T
Start date
2023-12-24
Primary completion
2024-12-24
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.